Jellagen develops collagen-based innovations to address regenerative medical needs, enabling the creation of medical treatments. The company's products utilize non-mammalian collagen sourced from jellyfish.

Jellagen

Jellagen develops collagen-based innovations for advanced wound and tissue healing, self-described as capable of addressing complex, regenerative medical needs.

Jellagen | 3,006 followers on LinkedIn. A Revolutionary Platform for Regenerative Medicine | Our jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next generation treatments and supporting current and future scientific research.

At the heart of our products is marine-sourced Collagen Type 0, an evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications.

Stéphane Thiroloix

Executive, Board Member, Investor, Advisor, ex-CMO Smith+Nephew

Andy Weymann

CEO at Jellagen

Thomas-Paul Descamps

Quality Manager at Jellagen

Rhodri Allen

We have an rare opportunity for someone to join the team at an exciting time for Jellagen. If you want more information or have any questions, please reach out to hr@jellagen.co.uk otherwise please apply for the role and we look forward to speaking to you.

Jellagen is excited to be attending MEDICA 2023 in Dusseldorf and to be part of the Welsh Pavilion of exhibitors (Hall 16 Booth H38). #investwales ; #Trade &InvestWales; #collagen ; #biomaterials ; #tissueengineering ; #medicaldevice

Jellagen is excited to announce the publication in Materials Today Bio results from new research developed in collaboration with the National Physical Laboratory (NPL) demonstrating further jellyfish Collagen Type 0 as the foundation for a range of new medical applications and to support new biological research. For full details, please follow the links: https://lnkd.in/grbf6um2 https://lnkd.in/gxhScGM8 #collagen #biomaterials #tissueengineering #marinebiotechnology #cellculture #medicaldevice #medicaldevices #collaboration #biotechnology #stemcells #3dcellculture #organoids

Metric
Company Name	Jellagen
Symbol
MSH ID	UK:CO:JELLAGEN
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Devices
Country	GB
Stage
Employee Count	1
Website	jellagen.co.uk
LinkedIn	jellagen
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CO

UK:CO:JELLAGEN

Jellagen

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue